Treatment of Trigger finger by ultrasound-guided needle release of a1 pulley: A series of 105 cases.


Journal

Joint bone spine
ISSN: 1778-7254
Titre abrégé: Joint Bone Spine
Pays: France
ID NLM: 100938016

Informations de publication

Date de publication:
11 2022
Historique:
received: 04 03 2022
revised: 24 05 2022
accepted: 31 05 2022
pubmed: 3 7 2022
medline: 24 11 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

We aimed to evaluate the efficacy and tolerance of A1 pulley release using the needle technique, under ultrasound guidance, in patients with symptomatic trigger finger. All patients with symptomatic trigger finger underwent A1 pulley release using an intramuscular 21 gauge (G) needle. Quinnell grade (I-IV), Quick Disabilities of Arm, Shoulder & Hand (QuickDASH) score (0-100) and pain score on a visual analog scale (VAS: 0-10mm) were recorded at inclusion. The primary endpoint was complete resolution of the trigger finger at 6 months. Eighty-four patients totaling 105 treated digits were included. Mean age was 63.3±10.7 years. Prior to treatment, mean VAS pain score was 5.8±2.6mm, and mean QuickDASH score was 44.3±19.1. At 6 months, disappearance of symptoms was achieved in 85 of 91 digits with follow-up (93.4%), and in 85.7% at 12 months. The absolute reduction in VAS pain and QuickDASH scores at 6 months was respectively 4.1±3.1 (P<0.001) and 36.1±20.7 (P<0.001), and 90% of patients reported being satisfied or very satisfied at 6 months. Long duration of symptoms was significantly associated with persistent trigger finger at 6 months after intervention. Complications were rare and minor. Tenosynovitis occurred in 5.7% of cases, for which a corticosteroid injection into the tendon sheath rapidly led to favorable resolution. Treatment of trigger finger by release of the A1 pulley under ultrasound guidance using the needle technique is a mildly invasive technique that yields rapid and effective symptom resolution with good tolerance up to 12 months.

Identifiants

pubmed: 35779790
pii: S1297-319X(22)00093-8
doi: 10.1016/j.jbspin.2022.105433
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105433

Informations de copyright

Copyright © 2022 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Clement Chopin (C)

Rheumatology department, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France. Electronic address: clement.chopin51@gmail.com.

Adrien Le Guillou (A)

Methodological assistance unit, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France.

Jean Hugues Salmon (JH)

Rheumatology department, Maison-Blanche hospital, Reims university hospitals, 45, rue Cognacq-Jay, 51092 Reims cedex, France.

Henri Lellouche (H)

Rheumatology department, Lariboisière hospital, université Paris-VII, 2, rue Ambroise-Paré, 75010 Paris, France.

Pascal Richette (P)

Rheumatology department, Lariboisière hospital, université Paris-VII, 2, rue Ambroise-Paré, 75010 Paris, France.

Jeremy Maillet (J)

Rheumatology department, Lariboisière hospital, université Paris-VII, 2, rue Ambroise-Paré, 75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH